Department of Urology, Texas Tech University Health Sciences Center, 3601 4th Street, Stop 7260, Lubbock, TX, 79430-7260, USA,
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
Clinical Outcome of Patients with Docetaxel-Resistant Hormone-Refractory Prostate Cancer Treated with Second-Line Cyclophosphamide-Based Metronomic Chemotherapy - Abstract
Your session will expire in 8 hours requiring you to log in each day to view content.
Subscribe
Editors Corner
Featured Conference
Upcoming Conference
GU Cancers Symposium 2012
February 2 - 4, 2012
San Francisco Marriott Marquis
San Francisco, CA USA
Prostate cancer session highlights sponsored by Bristol-Myers Squibb